`

Passage Bio

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$154.0M
size-icon Size
51 - 200

Frequently Asked Questions About Passage Bio

What does Passage bio do?+

We are a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these conditions. Our lead product candidate, PBFT02, seeks to treat neurodegenerative conditions, including frontotemporal dementia, by elevating progranulin levels to restore lysosomal function and slow disease progression. Our teams unwavering commitment to excellence is the driving force behind our mission to protect patients and their families against loss in neurodegenerative conditions

What is Passage bio's industry? +

Passage bio operates in the Biotechnology research industry.

What is Passage bio's revenue? +

Passage bio's revenue is 11m - 100m

What is Passage bio's company size? +

Passage bio has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.